SCHEDULE 13G: Ally Bridge Group Discloses 6.8% Passive Stake in Ceribell, Inc.
Beneficial Ownership Report
A group of investment entities led by Ally Bridge Group has disclosed a passive beneficial ownership of 6.8% in Ceribell, Inc., totaling 2,441,267 shares of common stock.
Summary
- ABG WTT-Ceribell Limited, ABG V-Ceribell Limited, Ally Bridge Group Global Life Science Capital Partners V, L.P., and several related entities, including Fan Yu, have jointly filed a Schedule 13G.
- The filing indicates a collective beneficial ownership of 2,441,267 shares of Ceribell, Inc. Common Stock.
- This aggregate amount represents 6.8% of Ceribibell, Inc.'s outstanding common stock.
- The percentage of ownership is based on 35,868,339 shares of Common Stock outstanding as of February 21, 2025, as reported in Ceribell's Form 10-K filed on February 25, 2025.
- The reporting persons hold shared voting power and shared dispositive power over all 2,441,267 shares, with no sole voting or dispositive power.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing disclosing beneficial ownership and does not contain subjective language or performance metrics that would indicate a strong positive or negative sentiment.
Positives
- The disclosure of a 6.8% passive stake by a group of investment entities led by Ally Bridge Group indicates significant institutional interest and confidence in Ceribell, Inc.
Future Outlook
NA
Industry Context
This filing is a standard regulatory disclosure of a significant passive investment by an institutional group in a publicly traded company, common in the life sciences and healthcare technology sectors where specialized investment funds often take positions.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by a reputable investment group may be viewed positively, potentially signaling increased institutional interest and stability in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (end of reporting period). |
| 02/21/2025 | Date as of which 35,868,339 shares of Common Stock of the Issuer were outstanding, as reported on the Issuer's Form 10-K. |
| 02/25/2025 | Date Ceribell, Inc. filed its Form 10-K, reporting outstanding shares. |
| 05/02/2025 | Date of filing of this Schedule 13G. |
Keywords
Ceribell Inc., Ally Bridge Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, SEC Filing, Passive Investment, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.